Curexo Inc.
060280.KQ
Get informed when a big investor buys or sells
+ FollowMarket Cap$355.66B
Close$
$-6751.24
186.8% downside
Current Fair Value
186.8% downsideOvervalued by 186.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $355.66 Billion |
|---|---|
| Enterprise Value | $340.20 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $67.76 |
| Beta | 0.63 |
| Outstanding Shares | 41,259,790 |
Return
| Return on Equity | 5.46% |
|---|---|
| Return on Assets | 4.95% |
| Return on Invested Capital | -1.52% |
Valuation & Multiples
| P/E Ratio | 64.41 |
|---|---|
| PEG | -16.99 |
| Price to Sales | 4.13 |
| Price to Book Ratio | 3.18 |
| Enterprise Value to Revenue | 4.38 |
| Enterprise Value to EBIT | -219.49 |
| Enterprise Value to Net Income | 61 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 13, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$21.50 B
Average shareholder expectationNext Earnings Call
Expected Date
November 16, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$18.70 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Curexo Inc.
99 employees
CEO: Jae-Joon Lee CUREXO, Inc. specializes in the creation and distribution of medical technology. The company's activities are organized across three primary divisions: Medical Robot, Implant, and Trade. Its Medical Robot segment focuses on advanced robo...